Journal of Ayurveda and Integrated Medical Sciences

2025 Volume 10 Number 8 August
Publisherwww.maharshicharaka.in

A Critical Review on Cardio Tonic Property of Karveera (Nerium indicum/Thevetia Peruviana)

Jagotra S1*, Kamboj P2
DOI:10.21760/jaims.10.8.36

1* Swati Jagotra, Assistant Professor, Dept of Dravya Guna, Motherhood Ayurveda Medical College and Hospital, Karaundi, Roorkee, Uttarakhand, India.

2 Parmod Kamboj, Assistant Professor, Dept of Panchkarma, Khalsa College of Ayurveda and Hospital, Nangal Kalan, Punjab, India.

Karveer/ Peet Karveer also known as Kaner or Oleander is a poisonous plant found commonly in North and Central India. It is an evergreen shrub which bears flowers of different colors from different varieties such as yellow, pink, white and red. Common species found of Karveer are Nerium indicum, Thevetia neriifolia/Thevetia peruviana, Nerium oleander. In many Ayurvedic texts, Karveer is classified as poisonous plant but along with the same it also has many medicinal properties. It is used in skin disorders, alopecia and wound healing and eye disorders. Beside that it also has cardio tonic property in very less doses. In this article focus will be on the cardiac property of both varieties of Karveer.

Keywords: Cardio tonic, Karveer, Kaner, Nerium Indicum

Corresponding Author How to Cite this Article To Browse
Swati Jagotra, Assistant Professor, Dept of Dravya Guna, Motherhood Ayurveda Medical College and Hospital, Karaundi, Roorkee, Uttarakhand, India.
Email:
Jagotra S, Kamboj P, A Critical Review on Cardio Tonic Property of Karveera (Nerium indicum/Thevetia Peruviana). J Ayu Int Med Sci. 2025;10(8):217-221.
Available From
https://jaims.in/jaims/article/view/4745/

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2025-06-13 2025-06-26 2025-07-07 2025-07-16 2025-07-26
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
None Nil Not required 11.32

© 2025 by Jagotra S, Kamboj P and Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Download PDFBack To ArticleIntroductionMaterials and MethodsDiscussionConclusionReferences

Introduction

In the world of medicine, Ayurveda have always been the richest source of plant based medicine along with the vast knowledge of health system in terms of prevention and cure. As per Ayurveda, every single thing on this earth can be used as medicine. Even the poisonous plants can be used as medicine if used in proper way and dose.

Karveer is classified as Upvisha as per Sushruta Samhita of Ayurveda. Being in Visha category, this plant still holds lot of medicinal properties and is being used in treatment of various diseases such as Kustharoga (Skin diseases), Bhagandara (Fistula), Netra Roga (Eye disease), Ashmari (kidney stones) etc. Due to presence of Peruvoside and cardenolides in this plant, it also exhibit cardio tonic activity such as of digitalis in very less dose. For this property it is used sometimes in Hrudya Daurbalya (heart failure).[1-4]

It comes in two varieties one is Nerium indicum commonly known as Oleander and other is Thevetia neriifolia/Thevetia peruviana commonly known as yellow oleander. They both are potent source of cardiac glycosides.[5]

Materials and Methods

Study Design

This is a narrative literature review focusing on the cardio tonic and pharmacological properties of Nerium indicum (Karveer) and Thevetia peruviana (Peet Karveer) based on classical Ayurvedic texts and modern biomedical research.

Source of Data

Classical Ayurvedic texts:

  • Charaka Samhita
  • Sushruta Samhita
  • Bhavaprakasha Nighantu
  • Sharangadhara Samhita
  • Ayurvedic Formulary of India (AFI)
  • Sahasrayogam

Modern scientific sources:

  • PubMed Central (PMC)
  • Google Scholar
  • Scopus
  • Ayurveda - specific journals (e.g., AYU, IJAMS, AYUSHDHARA etc.)

Botanical Description

Karveer/ Peet Karveer are a large evergreen shrub or small tree with around 10-12 feet of height and belong to Apocynaceae family. The stem contains milky juice. It has dark green color linear - lanceolate leaves, 4-6 inches long and 1 inch wide. Flowers are fragrant, bears different color as per varieties such as Nerium indicum have pink and white flowers, Thevetia neriifolia/Thevetia peruviana have yellow flowers. Fruit is cylindrical in shape, around 5-7inches long with hard follicles and contains small round brown color seeds.[6]

Varieties and Chemical composition

As per Ayurvedic Samhitas and Nighantus, there are two varieties of Karveer

1. Nerium indicum - It is of two types, one with red/pink flowers and other with white flowers. It has chemical components such as glycosides as of Neriodorin, Neriodorein, Karabin, Oleandrin, Rutin, β - D Digitaloside, Digitoxigenin etc. These are structurally similar to digoxin, a well-known cardiotonic drug.[7]

2. Thevetia peruviana/ Thevetia neriifolia - It has yellow flowers. It contains chemical constituents such as Peruvoside, Peruvosidic acid, Ruvoside, Neriifolin, Cerebin etc.[8]

Ras Panchak[9]

Nerium indicum (Karveer)

  • Rasa - Katu Tikta
  • Guna - Laghu, Ruksha
  • Virya - Ushna
  • Vipaka - Katu
  • Karma - Kapha-Vatahara, Kusthghana, Vranahara, Chakshushya

Thevetia peruviana

  • Rasa - Tikta, Kashaya, Madhur
  • Guna - Laghu, Snigdha
  • Virya - Sheeta
  • Vipaka - Madhur
  • Prabhava - Hrudya
  • Karma - Vata-Pitta Shaman, Shothahara

Cardio tonic Property of Karveer

Leaves and flowers of Nerium indicum inherits properties like cardio tonic, diaphoretic, diuretic, anticancer, antibacterial, anti-fungal, anti microbial. Leaves and flowers of Thevetia peruviana shows medicinal properties such as anti-bacterial, anti-cancerous, anti-spermatogenetic, anti-diarrhoeal, anti-microbial, cardio tonic etc. Both varieties have almost same ethno-medicinal properties and both have cardio tonic effect too.[10]

Charaka Samhita and Bhavaprakasha Nighantu describes Karveer as Hrudya (Cardiac tonic), Shothahara (Anti-inflammatory), Krimighna (Anthelmintic), Kaphahara (Removes phlegm/Kapha in channels) after Shodhana.[11-12]

While Acharya Sushruta does not directly indicates Karveer as Hrudya but his classification do say that it is Krimighna (antimicrobial/anti-toxic) Shothahara (anti-inflammatory) Lekhana (scraping effect - clears blocked channels).[13]

These actions indirectly support heart, especially in diseases involving Kapha accumulation, fluid retention (edema), and toxin-induced circulatory issues. In Uttara Tantra, Sushruta discusses Shotha Chikitsa which often occurs due to cardiac diseases. Karveer, being Kapha-Vatahara and Deepana, is likely used in compound formulations to improve circulation, reduce fluid retention, and thus relieve cardiac load.[14]

As per Acharya Priyavrat Sharma, Nerium indicum/ Thevetia peruviana have the same effects as that of digitalis on heart. Because of this reason it is cardio tonic/ cardio stimulant in very minimum amount. Indications of Karveer in case of heart failure are cardiac asthma, inflammation, severe weakness. As Karveer is a poisonous plant, it is fatal to heart if given in higher doses. The usual dose for the same is 2-3mg in powder form.[15]

Cardiac Glycosides Mechanism:[16]

  • Inhibit Na⁺/K⁺-ATPase enzyme in cardiac muscle cells.
  • Increases intracellular calcium, enhancing myocardial contractility (positive inotropic effect).
  • This makes them useful in congestive heart failure and arrhythmias - though therapeutic index is narrow.

Ayurvedic Applications in Cardiac Disorders

Table 1:

Ayurvedic DiagnosisModern CorrelationRole of Karveer
Hridroga (Heart disease)Congestive heart failureEnhances cardiac contractility (via glycosides)
Shotha (Edema)Cardiac edema or dropsyDiuretic, removes fluid accumulation
Swasa/Kasa (Breath disorders)CHF-related dyspneaClears congestion, supports cardiac output
Krimi (Parasites/toxins)Toxin-related inflammationDetoxifying action on blood and tissue

Clinical Evidence for use of Karveer as Cardio tonic

  • Adome et al. (2003) examined cardiostimulat-ory eff. of crude ethanolic oleander leaf extract on isolated guinea-pig hearts. They observed dose-dependent increases in force of contrac-tion, heart rate & cardiac output which is of same as of digoxin. Pig-heart model in which heartbeat was increased from 28 to 41beat/min, Blood flow increased from 0.4 to 1.9l/min and contraction amplitude from 22 to 49mm.[17]
  • Early pharmacological studies from the 1970s says that the Tincture of Karveer have potent cardio tonic effects and relief of cor pulmonale symptoms, aligning with Ayurvedic.[18]
  • Aclinical study on congestive heart failure patients using Karveer tincture observed improvements in respiratory symptoms and cardiac regulation, although detailed outcomes were not always published.

These provide rigorous preclinical evidence for positive inotropic effects, supporting traditional use.

Classical Formulation Used in Heart Diseases

  • Karveeradi Vati - used for cardiac conditions and Kapha disorders.[19]
  • Karviradi Kashayam - Used in chronic cough, edema, and cardiac weakness.[20]
  • Nimba Karviradi Taila - External application for skin and vascular conditions, but indirectly supports circulation.[21]

Discussion

Present review integrates classical Āyurvedic descr-iptions with modern experimental & clinical data to evaluate cardio tonic potential of 2 principal Karveer species - Nerium indicum & Thevetia peruviana.


Classical texts consistently attribute to properties of Karveer like Hṛidya, Śhothahara, Krimighna, Lekhana and KaphaVātahara (Bhavaprakasha; Sū. Sa. Kalpa 5.20; vide refs 11‑14). When these Guṇas are mapped onto modern patho physiology, they translate into positive inotropy, diuresis / anti‑ oedema, detoxification, and channel‑clearing effects, all of which are therapeutically valuable in congestive heart failure (CHF). From phyto-chemical point, both species are rich in cardenolide glycosides (oleandrin, peruvoside, etc.) that share canonical Na⁺/K⁺‑ATPase blockade → ↑[Ca²⁺]ᵢ → positive inotropic pathway (ref 16). Pre‑clinical organ bath and Langendorff studies (Adome et al., 2003; ref 17) reproducibly demonstrate digoxin‑like increase in contractile force, stroke volume and cardiac output, establishing robust mechanistic bridge between classical claims and laboratory findings.

Early human data, though methodologically modest, are congruent: two companion trials in the late 1970s reported clinically significant improvement in dyspnoea, peripheral oedema and exercise tolerance in CHF/cor‑pulmonale after low‑dose Tincture Karavīra (refs 18). These outcomes mirror the theoretical Ayurvedic indications of Hṛudya‑daurbalya and Śhotha, lending historical legitimacy to present‑day ethnomedical use.

Toxicology, however, remains the critical limitation. The therapeutic window is extremely narrow; doses exceeding 2–3 mg powdered leaf - or ingestion of a single T. peruviana seed - can cause fatal arrhythmias. Modern clinicians therefore avoid crude preparations, whereas classical Āyurveda emphasises Śhodhana procedures and micro‑dosing within polyherbal matrices (e.g., Karaveeradi Vati, Karveerādi Kaṣhaya). These compound formulations not only attenuate acute toxicity but also harness synergistic diuretic and Vāta‑Kapha‑palliative herbs, potentially widening the safety margin (refs 19‑21).

Conclusion

Karveer (Nerium indicum / Thevetia peruviana) embodies a striking paradox: potent digitalis ‑ like cardiotonic efficacy at micro‑doses and lethal cardiotoxicity at only modestly higher exposures. Classical Ayurvedic texts anticipated this duality, classifying the drug among Upavisha yet recommending it - after rigorous purification - for disorders characterized by Kapha‑Vāta congestion, edema and cardiac debility.

Contemporary pharmacology confirms the mechanistic rationale via Na⁺/K⁺‑ATPase inhibition and consequent positive inotropy, while pre‑clinical and limited clinical data suggest symptomatic benefit in CHF.

In its current form, Karveera is best regarded as a research lead and an adjuvant in expert Ayurvedic practice, not a stand‑alone cardio tonic for routine clinical use. Future progress hinges on (i) phytochemical standardization of traditional formulations, (ii) modern dose‑finding and safety trials, and (iii) derivation of safer glycoside analogues. Until such evidence accrues, meticulous dose control, polyherbal buffering, and toxicovigilance remain mandatory to convert Karveer’s ancient promise into a scientifically validated therapeutic option.

References

1. Sushruta Samhita. Kalpasthana, Sthavarvishavigyaniya Adhyaya, Chapter 2, Verse 5. p. 518. [Crossref][PubMed][Google Scholar]

2. Sushruta Samhita. Chikitsasthana, Kushthachikitsa Adhyaya, Verses 54–56. Varanasi: Chaukhambha Subharati Prakashan; 2001. p. 258 [Crossref][PubMed][Google Scholar]

3. Charaka Samhita. Chikitsa Sthana, Kushthachikitsa Adhyaya, Chapter 7, Verse 128. p. 324. [Crossref][PubMed][Google Scholar]

4. Vagbhatta. Ashtanga Hridaya. Chikitsa Sthana, Kushthachikitsa Adhyaya, Chapter 19, Verse 61. Tripathi B, editor. Delhi: Chaukhambha Samskrita Pratishthana; 2003. p. 791 [Crossref][PubMed][Google Scholar]

5. Sharma PV. Dravyaguna Vijnana. Vol II, Chapter 3. Varanasi: Chaukhambha Bharti Academy; 2019. p. 211–214 [Crossref][PubMed][Google Scholar]

6. Chaudhari A, Singh B. A critical review of Karvira (Nerium indicum Mill). Int J Ayurveda Med Sci. 2016;1(2):51–5. [Crossref][PubMed][Google Scholar]

7. Sharma PV. Dravyaguna Vijnana. Vol II, Chapter 3. Varanasi: Chaukhambha Bharti Academy; 2019. p. 211–214 [Crossref][PubMed][Google Scholar]

8. Sharma PV. Dravyaguna Vijnana. Vol II, Chapter 3. Varanasi: Chaukhambha Bharti Academy; 2019. p. 211–214 [Crossref][PubMed][Google Scholar]


9. Sharma PV. Dravyaguna Vijnana. Vol II, Chapter 3. Varanasi: Chaukhambha Bharti Academy; 2019. p. 211–214 [Crossref][PubMed][Google Scholar]

10. Al-Snafi AE. Bioactive ingredients and pharmacological effects of Nerium oleander. IOSR J Pharm. 2020;10(9, Ser. I):19–32 [Crossref][PubMed][Google Scholar]

11. Bhavaprakasha Nighantu. Haritakyadi Varga. Verses 101–102. . [Crossref][PubMed][Google Scholar]

12. Charaka Samhita. Kalpa Sthana, Chapter 1, Verse 7. Sharma RK, Dash B, editors. Varanasi: Chaukhamba Sanskrit Series Office; 2014. [Crossref][PubMed][Google Scholar]

13. Sushruta Samhita. Kalpa Sthana, Chapter 5, Verse 20. Dalhana, commentator. Varanasi: Chaukhambha Visvabharati; 2014. [Crossref][PubMed][Google Scholar]

14. Sushruta Samhita. Uttara Tantra, Chapter 13, Verse 9. Dalhana, commentator. Varanasi: Chaukhambha Visvabharati; 2014. [Crossref][PubMed][Google Scholar]

15. Sharma PV. Dravyaguna Vijnana. Vol II, Chapter 3. Varanasi: Chaukhambha Bharti Academy; 2019. p. 211–214 [Crossref][PubMed][Google Scholar]

16. Katzung BG, Vanderah TW, Trevor AJ. Basic and Clinical Pharmacology. 14th ed. New York: McGraw-Hill Education; 2018. p. 165–166 [Crossref][PubMed][Google Scholar]

17. Dey P, Chaudhuri TK. Pharmacological aspects of Nerium indicum Mill: A comprehensive review. Ayu. 2014;8(16):156–62. [Crossref][PubMed][Google Scholar]

18. Trivedi VP, Nesamony S, Sharma VK. A clinical study of the effects of Tincture Rakta Karveer Patra (Nerium indicum Linné) on the respiratory tract involvement in cases of congestive heart failure. Q J Crude Drug Res. 1978;16(4):176–84. [Crossref][PubMed][Google Scholar]

19. Government of India. The Ayurvedic Formulary of India. Part II. 1st ed. New Delhi: Dept. of ISM&H, Ministry of Health & Family Welfare; 2000. p. 338–341 [Crossref][PubMed][Google Scholar]

20. Murthy KRS, editor and translator. Sahasrayogam (A Thousand Formulas). English Rev. 4. Varanasi: Chaukhambha Orientalia; 2012. p. 330–331 [Crossref][PubMed][Google Scholar]

21. Sharma PV. Śārṅgadhara Saṃhitā. 3rd ed. Varanasi: Chaukhambha Bharati; 2018. Madhyama Khaṇḍa, Taila Kalpa, Verse 78(b). p. 177–178 [Crossref][PubMed][Google Scholar]

Disclaimer / Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of Journals and/or the editor(s). Journals and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.